James Pursley files Form 144 for 15,000 HNGE shares

James Pursley reported a planned sale of 15,000 common shares of HNGE under a 10b5-1 arrangement.

Rhea-AI Filing Summary

James Pursley reported a planned sale of 15,000 common shares of HNGE under a 10b5-1 arrangement. The filing shows the sale date 12/22/2025 and a gross sale amount of $725,950.50. The shares trace to Performance Stock Units dated 04/01/2023.

Insights

Corporate Governance Analyst

Insider sale recorded under a 10b5-1 plan: routine disclosure of a planned disposition.

The filing lists a 10b5-1 sale by James Pursley of 15,000 common shares with a reported gross amount of $725,950.50 on 12/22/2025. The shares are linked to Performance Stock Units dated 04/01/2023.

Such filings are typically administrative and depend on plan terms; cash-flow treatment and any lockups are not shown in the excerpt. Subsequent public filings would show actual transaction settlement details.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did HNGE insider James Pursley disclose in the Form 144?

The filing discloses a planned sale of 15,000 common shares by James Pursley under a 10b5-1 plan. The reported sale date is 12/22/2025 with a gross amount of $725,950.50.

Are the sold shares for HNGE from stock awards or open‑market holdings?

The disclosure ties the shares to Performance Stock Units dated 04/01/2023. The filing indicates the securities originate from those award units rather than an unspecified open‑market holding.

How much cash is reported from the planned HNGE sale?

The Form 144 shows a reported gross sale amount of $725,950.50. The excerpt does not break out net proceeds, taxes withheld, or settlement details beyond that gross figure.

When was the HNGE sale scheduled to occur per the filing?

The filing lists the sale date as 12/22/2025 under a 10b5-1 sales plan. The excerpt provides that specific date for the planned disposition.

Does the Form 144 show any trading restrictions or lockups for these HNGE shares?

The provided excerpt does not include language about trading restrictions or lockups. It lists the security type and award date but does not specify post‑award restrictions or holding periods.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/23/2026 - 04:30 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001783108
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Hinge Health, Inc.
SEC File Number	001-42657
Address of Issuer	455 Market Street, Suite 700 San Francisco CALIFORNIA 94105
Phone	4157262206
Name of Person for Whose Account the Securities are To Be Sold	JAMES PURSLEY
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	15000	619650.00	37919155	02/23/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/01/2023	Performance Stock Units	Issuer			15000	04/01/2023	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for JAMES PURSLEY 455 Market Street, Suite 700 San Francisco CA 94105	Common	12/22/2025	15000	725950.50

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the vesting of performance stock units during the period of 4/1/2023 through 3/31/25
Date of Notice	02/23/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/13/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ James Pursley
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)